Therapeutics News and Research

RSS
Novel therapeutic agent could be effective for treating cancers with certain gene mutations

Novel therapeutic agent could be effective for treating cancers with certain gene mutations

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

New radiotracer opens the door for advancement of iron-targeted cancer therapies

New radiotracer opens the door for advancement of iron-targeted cancer therapies

Researchers discover camelid-derived two nanobodies that target SARS-CoV-2

Researchers discover camelid-derived two nanobodies that target SARS-CoV-2

Aptamer Group and WuXi AppTec Research Service Division collaborate to identify new Optimer™ enabled therapeutics

Aptamer Group and WuXi AppTec Research Service Division collaborate to identify new Optimer™ enabled therapeutics

Researchers develop a transferrable and integrative type I CRISPR-based platform to edit superbugs

Researchers develop a transferrable and integrative type I CRISPR-based platform to edit superbugs

Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

Synergistic multi-antibody cocktail protects against SARS-CoV-2 in animal model

Cell-analysis method could pave the way for new vaccine strategies against tuberculosis

Cell-analysis method could pave the way for new vaccine strategies against tuberculosis

Research provides new insight into uncontrolled inflammation in COVID-19 patients

Research provides new insight into uncontrolled inflammation in COVID-19 patients

SARS-CoV-2 genomic surveillance identifies intricacies of stabilizing vs. destabilizing mutations

SARS-CoV-2 genomic surveillance identifies intricacies of stabilizing vs. destabilizing mutations

New digital health technologies could lead to better care for Parkinson’s disease

New digital health technologies could lead to better care for Parkinson’s disease

SP’s fill-finish system chosen by NIBRT to deliver advanced training in biopharmaceutical production

SP’s fill-finish system chosen by NIBRT to deliver advanced training in biopharmaceutical production

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

A path to treat currently untreatable cases of cystic fibrosis is clearly achievable, study suggests

A path to treat currently untreatable cases of cystic fibrosis is clearly achievable, study suggests

Researchers find a potentially game-changing blood clot treatment

Researchers find a potentially game-changing blood clot treatment

Researchers use appendiceal cancer organoids to study personalized immunotherapy response

Researchers use appendiceal cancer organoids to study personalized immunotherapy response

New research may offer clues to why MS patients develop progressive disability

New research may offer clues to why MS patients develop progressive disability

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Scientists divide all cancers into two categories

Scientists divide all cancers into two categories